IL-1,

Jianwu Huang1,2,3, Wenlong Kuang4,5, Zihua Zhou6,7,8

  • 1Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.

Inflammopharmacology
|April 27, 2024
PubMed
概括

向炎症,特别是互白素-1 (IL-1),对治疗心肌梗塞 (MI) 和改善心脏病发作后的心脏功能有希望. 这种方法可以减少不良的左心室重塑和炎症.